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A key role is emerging for the cytoskeleton in coordi-
nating receptor signaling, although the underlying
molecular requirements remain unclear. Here we
show that cytoskeletondisruption triggered signaling
requiring not only the B cell receptor (BCR), but also
the coreceptor CD19 and tetraspanin CD81, thus
providing a mechanism for signal amplification
upon surface-bound antigen stimulation. By using
superresolution microscopy, we demonstrated that
endogenous IgM, IgD, and CD19 exhibited distinct
nanoscale organization within the plasmamembrane
of primaryB cells. Upon stimulation, we detect a local
convergenceof receptors, although their global orga-
nization was not dramatically altered. Thus, we
postulate that cytoskeleton reorganization releases
BCR nanoclusters, which can interact with CD19
held in place by the tetraspanin network. These
results not only suggest that receptor compartmen-
talization regulates antigen-induced activation but
also imply a potential role for CD19 in mediating
ligand-independent ‘‘tonic’’ BCRsignaling necessary
for B cell survival.
INTRODUCTION
Signaling through immunoreceptors, including the B cell
receptor (BCR), T cell receptor (TCR), and high-affinity IgE
receptor (FcεRI), is triggered by ligand engagement and leads
to cellular activation. These receptors lack intrinsic tyrosine
kinase activity and, as a result, signaling is triggered through
phosphorylation of immunoreceptor tyrosine-based activation
motifs (ITAMs) within the associated Iga/b sheath, CD3 complex,
or g chain tail for BCR, TCR, and FcεRI, respectively (Reth, 1989;
Weiss and Littman, 1994). It has been reported that FcεRI is
distributed in small clusters within membrane sheets of mast
cells (Wilson et al., 2000) and it has been suggested that the
TCR exists in oligomeric structures in resting lymphocytemembranes (Schamel et al., 2005). In line with this, more recent
imaging approaches have visualized pre-existing clusters of
TCR, termed ‘‘protein islands,’’ that colocalize with various lipids
and the actin cytoskeleton (Lillemeier et al., 2006). In the case of
B cells, early biochemical methods suggest that the BCR might
exist in oligomeric complexes (Schamel and Reth, 2000).
Although intermolecular interactions between BCRs were not
detected by Fo¨rster resonance energy transfer (FRET) in resting
J558L B cells (Tolar et al., 2005), it has emerged that the BCR has
an intrinsic capacity to form oligomers in the absence of ligand
(Yang and Reth, 2010b). However, it remains unclear whether
such oligomers exist on the surface of primary B cells and if so
what is their size and molecular composition, and, importantly,
how they influence B cell activation.
B cells recognize antigen on the surface of presenting cells
in vivo (Cyster, 2010). The recognition of such physically con-
strained antigen requires considerable alteration of the B cell
morphology and indeed a role is now emerging for the underlying
cytoskeleton in coordinating and regulating themolecular events
of B cell activation (Harwood and Batista, 2010). In line with this,
reorganization of the actin cytoskeleton is required for the forma-
tion of BCRmicroclusters (Treanor et al., 2011). The formation of
these signaling-competent microclusters is the earliest visible
event associated with successful B cell activation (Depoil et al.,
2008; Sohn et al., 2008). This molecular reorganization is accom-
panied by the actin-dependent spreading across the antigen-
presenting surface to increase the amount of antigen gathered
by the B cell (Fleire et al., 2006). Several recent studies have
begun to define the molecular linkage between the BCR and
the cytoskeleton, identifying roles for the cytoskeleton regulators
Vav, Rap, cofilin, and WASP (Freeman et al., 2011; Lin et al.,
2008; Meyer-Bahlburg et al., 2008; Weber et al., 2008). More-
over, the importance of such regulators is established by the
observation that mutations in these molecules are associated
with the development of human primary immunodeficiencies
(Conley et al., 2009).
Alongside activation, the actin cytoskeleton plays a role in re-
straining signaling in resting B cells (Baeker et al., 1987; Treanor
et al., 2010). Furthermore, we have shown that the underlying
cytoskeleton network regulates the BCR diffusion by defining
micron-sized compartments in the B cell membrane (Treanor
et al., 2010). These observations suggest that the organizationImmunity 38, 461–474, March 21, 2013 ª2013 Elsevier Inc. 461
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this is regulated at the molecular level remains unclear. The
significance that such organization might have in mediating the
low constitutive tonic signaling essential for B cell development
and survival (Lam et al., 1997) has not been established. Here,
we visualize endogenous IgM, IgD, and CD19 and show they
are organized as pre-existing nanoscale clusters on the surface
of resting primary B cells. Moreover, through a combination of
genetic dissections, imaging, and biochemical methods, we
show that effective BCR signaling requires collaboration with
the coreceptor CD19 organized by the CD81-tetraspanin
network. On the basis of these findings, it appears that signaling
through the BCR is regulated by the differential compartmental-
ization of receptors in the plasma membrane through the
combined action of the actin cytoskeleton and the tetraspanin
network.
RESULTS
Cytoskeleton Disruption Triggers Intracellular Signaling
through the BCR
In the absence of antigen, disruption of the actin cytoskeleton in
resting B cells is sufficient to trigger intracellular signaling that is
reminiscent of that seen during antigen-induced activation (Trea-
nor et al., 2010); however, it has not been establishedwhether the
BCR itself is required for this signaling. To address this, we have
taken advantage of a transgenic mouse model in which BCR
expression is genetically ablated by cre-mediated recombination
inmatureBcells (Srinivasanet al., 2009). AlongsideB1-8f IgHand
Cd21-cre, thesemiceexpress theEm-Bcl2 transgene tocompen-
sate for the lackof tonic survival signal inBcellswithoutBCR (Fig-
ure 1A; Strasser et al., 1991), and thus primary B cells purified
from these mice can be kept in culture for up to 10 days with no
detectable impairment in viability (unpublished data).
We found that whereas 4% of primary B cells purified from
these mice express only IgM and essentially none express only
IgD, around 14% lacked expression of both IgM and IgD (Fig-
ure 1B). As such, we used the expression of IgM to discriminate
between BCR+ (IgM+) and BCR (IgM) cells and found these
cells tobesimilar in sizeandexpressionofCD19, though the latter
population exhibited a slightly reduced amount of B220 (Fig-
ure 1C). Primary B cells were simultaneously labeled with a fluo-
rescent Fab fragment against IgM and the dye INDO-1 in order to
monitor calcium flux relative to BCR expression by flow cytome-
try.Weobserved thatBCR-deficientBcellswereunable to trigger
calcium signaling in response to treatment with either surrogate
antigen (anti-IgM F(ab)2) or disruption of the actin cytoskeleton
through the actin polymerization inhibitor Cytochalasin D (CytoD;
Figures 1Dand 1E) or actinmonomer-sequestering agent Latrun-
culin A (LatA; data not shown). In contrast, those B cells express-
ing BCR were able to mount robust and equivalent intracellular
signaling after either BCR cross-linking or cytoskeleton disrup-
tion, thus establishing that the BCR is required for actin alter-
ation-induced signaling in resting B cells.
BCR Organization into Nanoclusters Is Not Altered after
Cytoskeleton Disruption
To examine whether this BCR-mediated signaling was associ-
ated with a marked reorganization of the BCR in the membrane,462 Immunity 38, 461–474, March 21, 2013 ª2013 Elsevier Inc.we implemented the superresolution microscopy method direct
stochastic optical reconstruction microscopy (dSTORM) (Heile-
mann et al., 2008) to visualize the molecular organization of
endogenous BCR in primary B cells. This method overcomes
the resolution limit associated with conventional light micros-
copy, allowing localization of endogenous receptors to a position
accuracy of 10–30 nm in fixed cells. Primary B cells were labeled
with Fab fragments against either of the two BCR isotypes ex-
pressed by primary B cells, IgM and IgD, that were conjugated
with the dSTORM-compatible fluorophore Cy5. These cells
were then settled under nonstimulatory conditions on anti-major
histocompatibility complex class II glycoprotein (MHCII)-coated
surface for 4 min prior to fixation to allow adhesion of cells to the
coverslip. To visualize selectively BCR in close proximity to the
surface, samples were imaged by total internal reflection fluores-
cence microscopy (TIRFM). The dSTORM method involves
switching the fluorophores into a metastable dark state, prior
to multiple rounds of activation with a continuous low-intensity
illumination to trigger stochastic transition of molecules to a fluo-
rescent state for imaging. Indeed after 2,000–5,000 cycles, we
were able to visualize up to 10,000 single molecules of BCR.
We have quantified that B cells express approximately 20,000–
150,000 molecules of IgM and 250,000–300,000 molecules of
IgD (Figures S1A and S1B available online), and so this means
that we visualized around 10%of IgM or 6%of IgD at the contact
surface by our dSTORM approach (Supplemental Experimental
Procedures). By generating reconstructed images from these
localization coordinates, the resolution of imaging was improved
around 10-fold compared with light microscopy (Figure 2A;
Supplemental Experimental Procedures). Visual inspection of
these images readily revealed that IgM and IgD were not homo-
genously distributed in the resting B cell membrane. Instead,
both BCRs were organized into nanoscale clusters, with IgD
more densely clustered than IgM.
We have used two alternative methods to quantify the extent
of both IgM and IgD clustering in resting B cells as seen by
dSTORM (Zhang et al., 2006). First, we used the Hopkins index
to ascertain the extent to which BCR displayed a nonrandom
distribution on the B cell surface (Figures 2B, S1C, and S1D;
Supplemental Experimental Procedures). In line with our visual
inspection, both BCR isotypes had a Hopkins index that was
significantly higher than expected for a fully random distribution
(0.5), demonstrating that IgM and IgD (Hopkins index of 0.66 and
0.83, respectively) are not randomly distributed in the resting
B cell membrane. Moreover, the predominant isotype IgD was
more likely to be found in nanoscale clusters on the B cell surface
compared with IgM. Second, we used the H function derived
from Ripley’s K function to quantify the extent of BCR clustering
according to the number of proteins foundwithin a distance (r) for
eachmolecule compared with that predicted for a random distri-
bution (Figures 2B, S1C, and S1D; Supplemental Experimental
Procedures). We found that IgD nanoclusters were significantly
more densely packed compared with IgM, though the radius of
clusters observed for both isotypes (given as the peak of the H
function curve) was similar at around 60–80 nm. With that value
and taking into consideration the contact surface area and the
amount of BCR (Figures S1A, S1B, and S1E–S1I; Supplemental
Experimental Procedures), we found 70%of IgD in nanoclusters,
which could be estimated to contain approximately 30–120
Figure 1. Disruption of the Actin Cytoskel-
eton Leads to BCR Signaling
(A) Schematic representation of the transgenic
strategy used to obtain BCR B cells. B1-8f Igh
transgene is deleted by cre-mediated recombina-
tion upon expression of CD21 after B cell matu-
ration. Em-Bcl2 transgene increases the viability
and thus compensates for the lack of BCR-medi-
ated survival signal.
(B) Flow cytometry analysis of the purified B220+
splenic B cells from these mice. A mixture of IgM,
IgD double-positive (81%) and double-negative
(14%) populations (left) was detected.
(C) B cells were classified as IgM and IgM+ pop-
ulations according to (B, right) and the pop-
ulations’ cell size, expression of CD19 and B220
were compared.
(D and E) The cells were stained with ATTO 633-
conjugated anti-IgM Fab fragment to distinguish
(D) IgM+ and (E) IgM populations andwith INDO-1
to follow the amount of intracellular calcium upon
stimulation with either 10 mg/ml of anti-IgM F(ab)2
(top) or with 50 mM CytoD (bottom) by flow
cytometry.
Data are representative of three experiments.
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Figure 2. IgD and IgM Exist in Preformed Nanoclusters that Are Not Altered upon Disruption of the Actin Cytoskeleton
(A–C) Primary B cells were stained with Cy5-conjugated anti-IgD or anti-IgM Fab fragments and settled on nonstimulatory anti-MHCII-coated coverslips. Cells
were then fixed, imaged, and processed for dSTORM.
(legend continued on next page)
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Membrane Organization Regulates BCR Signalingmolecules; although only 38% of IgM resided in nanoclusters
with around 20–50 molecules per cluster (Figure 2C). Similar
organization of receptors was found on cells adhered to fibro-
nectin-coated coverslips, indicating that the organization was
not induced by tethering via MHCII (Figure S1J and data not
shown). Our data show that IgM and IgD exist in distinct pre-
formed nanoscale clusters in unstimulated primary B cells.
We then moved on to visualize the impact of the disruption of
the actin cytoskeleton on BCR organization. Primary B cells were
labeled as before and adhered to nonstimulatory coverslips,
prior to a 4 min treatment with LatA to inhibit actin polymeriza-
tion. dSTORM images of IgM and IgD were generated and
analyzed by both Hopkins index and the H function, as above
(Figures 2D and 2E). At these early stages, the extent of clus-
tering of either BCR isotype was not significantly altered during
signaling triggered by cytoskeleton disruption. This was in
contrast to the marked increase in receptor clustering observed
when the BCRwas heavily cross-linked (Figures 2F and 2G). Our
results indicate that robust BCR signaling can occur even in the
absence of heavily cross-linking the BCR. We suggest that,
rather than altering the nanocluster organization of BCR, disrup-
tion of the cytoskeleton abolishes diffusion barriers such that ex-
isting BCR nanoclusters become more mobile.
BCR Signaling after Cytoskeleton Disruption Requires
Recruitment of Intracellular Effectors by CD19
The release of BCR nanoclusters after disruption of the cortical
cytoskeleton could potentially allow access to activatory core-
ceptors, such as CD19, which would facilitate signaling through
the BCR. CD19 is required for induction of effective humoral
immune responses in mouse and human (Conley et al., 2009;
Rickert et al., 1995), though themolecular mechanism underlying
this requirement has not yet been established.
To investigate a potential role for CD19 in mediating BCR
signaling in response to cytoskeleton disruption, we examined
the capacity of primary B cells from CD19-deficient mice to
initiate intracellular calcium signaling upon cytoskeleton disrup-
tion (Figures 3A–3C). Surprisingly, CD19-deficient B cells were
completely unable to initiate calcium signaling upon treatment
with either LatA or CytoD (Figures 3A and S2A). Importantly,
because these cells remain refractory to stimulation even after(A) Left: Pseudo-TIRFM image from unprocessed sum of all acquired frames. M
zations; the magnified region (1.5 3 1.5 mm) in dashed white square is shown as
(B) Quantification of the distribution of IgD and IgM by (left) Hopkins index and (r
(C) An example of the quantification of molecules classed as residing inside (IgD,
radius. The percentages of clustered molecules are shown in brackets. Area of 3
(D and E) Primary B cells were stained as above, settled on nonstimulatory cove
fixed, imaged, and processed for dSTORM.
(D) Representative cells stained for (top) IgD and (bottom) IgM. dSTORM image (
surface plot (right).
(E) Quantification of the distribution of (top) IgD and (bottom) IgM by (left) Hopkin
(F and G) Primary B cells were stained with (top) Cy5-conjugated anti-IgD Fab
antibody or (bottom) with increasing concentrations of Cy5-conjugated anti-IgM F
for dSTORM.
(F) Representative cells stained for (top) IgD and (bottom) IgM. dSTORM image (
surface plot (right).
(G) Quantification of the distribution of (top) IgD and (bottom) IgMby (left) Hopkins
denote mean ± SEM.
***p < 0.0001. Scale bars represent 1 mm (A, D, F). For additional information, see
three (A–E) or two (F, G) experiments and minimum of nine cells per experiment.incubation with high concentrations of CytoD, this suggests
that they do not simply have a higher threshold of activation,
but rather that CD19 plays a more fundamental role in mediating
this mode of signaling. CD19-deficient cells were also unable to
phosphorylate downstreammediators such as ERK andAkt after
LatA or CytoD treatment (Figures 3B, 3C, and S2B). This defect in
early signaling was not due to altered rigidity of the actin cyto-
skeleton or abnormal expression of BCR in CD19-deficient cells
(Figures S2C–S2E). The requirement for CD19 in mediating BCR
signaling in response to cytoskeleton disruption is reminiscent of
that subsequent to stimulation with membrane antigen (Depoil
et al., 2008); though, as previously shown, this requirement in
mediating BCR signaling can be overridden by heavily cross-
linking the BCR (Figures 3D–3F and S2A; Fujimoto et al., 1999;
Sato et al., 1997).
We went on to probe whether the requirement for CD19 was
dependent on the recruitment of cytoplasmic effectors (Fearon
and Carroll, 2000). To do this, we used primary B cells isolated
from transgenic mouse models that were deficient in CD19 and
reconstituted with three different mutations of CD19 that
disrupt binding of various combinations of intracellular effec-
tors, namely: CD19-2F (Y482F, Y513F) that cannot bind Lyn
and PI3K; CD19-3F (Y391F, Y421F, Y490F) that cannot bind
Vav, PLCg2, and Abl; and CD19-2Y (Y391F, Y403F, Y421F,
Y443F, Y490F) that cannot bind Vav, PLCg2, Abl, and Fyn (Fig-
ure 3G). We observed that the calcium signaling after treatment
with LatA was most dramatically impaired in the CD19-3F and
CD19-2Y B cells (Figure 3H). Because this defect in calcium
signaling recapitulates the one found in B cells deficient in
Vav1 and Vav2 or in PLCg2 (Figure 3I), this demonstrates that
CD19 drives the recruitment of these intracellular signaling
mediators to greatly amplify signaling through the BCR. Inter-
estingly, B cells expressing CD19-2F mimicked the slight delay
in calcium signaling after LatA treatment observed in primary B
cells deficient in PI3Kd (Figures 3H and 3I), suggesting that
CD19 also recruits PI3K during BCR-mediated calcium
signaling. However, PI3Kd-deficient but not CD19-2F mutant
B cells were severely impaired in their ability to phosphorylate
Akt and ERK, so it appears that other proteins might mediate
PI3K recruitment for MAP-kinase (MAPK) activation (Figures
S2F–S2H).iddle and right: dSTORM images reconstructed from single-molecule locali-
2D image (middle and right) and 3D surface plot (right).
ight) H function.
red; IgM, green; random distribution, black) or outside (gray) clusters of 80 nm
3 3 mm.
rslips, and treated with vehicle control or 1 mM LatA for 4 min. Cells were then
left) with magnified region (1.5 3 1.5 mm) in dashed white square shown as 3D
s index and (right) H function.
fragments with increasing concentrations of cross-linking secondary anti-rat
(ab)2 fragments, settled on nonstimulatory coverslips for 4 min, and processed
left) with magnified region (1.5 3 1.5 mm) in dashed white square shown as 3D
index and (right) H function. Error bars (Hopkins index) and thin lines (H function)
Supplemental Experimental Procedures and Figure S1. Data are pooled from
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Figure 3. BCR Signaling in Response to Cytoskeleton Disruption Requires CD19-Dependent Recruitment of Vav, PLCg2, and PI3K
(A–C) Wild-type (WT) and CD19-deficient primary B cells were treated with 1 mM LatA.
(A) Ratiometric intracellular calcium flux in (top) WT and (bottom) CD19-deficient B cells measured by flow cytometry.
(legend continued on next page)
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mediated recruitment of key regulators is essential for the trig-
gering of BCR signaling after cytoskeleton disruption. This is in
line with the concept that the cortical cytoskeleton establishes
barriers to compartmentalize BCR nanoclusters from activatory
coreceptors such as CD19.
The Tetraspanin CD81Organizes and Immobilizes CD19
Nanoclusters
In view of the essential role of CD19 for activation, we wondered
whether, similarly to the BCR, the actin cytoskeleton might regu-
late the diffusion of this coreceptor. We performed single-
particle tracking of CD19 by incubating primary B cells with
limited amounts of fluorescently labeled anti-CD19 Fab fragment
and by TIRFM, as we described previously for BCR (Figures 4A–
4F and S3A–S3H; Treanor et al., 2010). In resting cells, we
observed that themobility of a large proportion of CD19 particles
appeared very low, with a minority exhibiting higher mobility
(Figures 4A and 4B; Movie S1). The median diffusion coefficient
was 0.006 mm2/s, similar to IgD but considerably slower than that
observed for IgM in resting B cells (Figure S3A). Notably, the
diffusion of CD19 was not accelerated after treatment with
LatA as evidenced by both the median diffusion coefficient and
the area of confinement (Figures 4C and S3B–S3F; Supple-
mental Experimental Procedures), a behavior that is in contrast
to that observed for the BCR (Figures 4C and S2E; Treanor
et al., 2010). Supporting these observations, experiments with
primary B cells expressing the F-actin binding probe LifeAct-
GFP showed that CD19 diffusion was independent of the density
of the actin cytoskeleton (Figures S3G and S3H).
In order to understand the molecular mechanism of CD19
immobilization,weconsideredothermolecules that could control
its behavior. CD19 has been found in a complex with a comple-
ment receptor, CD21, and a tetraspanin protein, CD81 (Fearon
and Carroll, 2000). Because tetraspanins are known to be
capable of organizing proteins at the plasma membrane, we
examined the diffusion of CD19 in CD81-deficient primary B cells
as above (Figures 4D–4F, S3I, and S3J). Particles of CD19
diffused up to 3-fold faster and explored larger areas in CD81-
deficient cells compared with wild-type B cells. A more detailed
analysis revealed two different populations of CD19 in wild-type
cells, with 82% of CD19 belonging to a slower diffusing popula-
tion (centered around D = 0.0035 mm2/s) and with 18% retaining
higher mobility (centered around D = 0.0330 mm2/s) (Figures 4D
and 4E; Supplemental Experimental Procedures). CD19 diffusion
shifted strongly to the fastermoving population inCD81-deficient
cells, indicating that the majority of CD19 is restrained by the tet-(B and C) B cells were treated with vehicle control for 5 min (DMSO, -) or LatA fo
immunoblotting with phospho-Akt (Ser473 and Thr308), phospho-ERK1 and 2 (p
(B) Immunoblot.
(C) Quantification of p-ERK and p-Akt.
(D–F) Wild-type (WT) and CD19-deficient primary B cells were examined as abov
(G) Schematic representation of human CD19. The nine intracellular phosphoryla
interaction partners. The constructs used are CD19-2F (Y482F, Y513F); CD19-3F
TM, transmembrane domain.
(H) Ratiometric intracellular calcium flux induced by (left) 10 mg/ml of anti-IgM F(ab
CD19-2F, (third row) CD19-3F, and (bottom) CD19-2Y.
(I) Primary B cells purified from mice deficient in PI3Kd, Vav1 and Vav2, and PLC
Data are representative of a minimum of three experiments. See also Figure S2.raspanin network. As expected, the rate of BCR diffusion and
area of confinement were not altered in CD81-deficient cells
(Figures 4F and S3J and data not shown). Importantly, we found
that the absence of CD81 rendered CD19 diffusion partially
dependent on the integrity of the actin cytoskeleton (Figure 4F).
Thus, the CD81-tetraspanin network, rather than the actin
cytoskeleton, is primarily responsible for the regulation of
CD19 diffusion. But does this relate to themolecular organization
of CD19? To investigate this, we performed dSTORM of CD19 in
primary B cells (Figures S3K and S3L). Quantitative analysis re-
vealed that CD19 exhibited clustering that was intermediate
between IgM and IgD. Similar to the diffusion, LatA treatment
did not alter CD19 organization. However, the absence of
CD81 altered the organization of CD19 (Figure 4G). Although
the radius of the CD19 nanoclusters did not change, the molec-
ular density of CD19 within these clusters increased by around
80% (Figure 4H). This would be in line with a mechanism
whereby CD19 is immobilized and organized through CD81 to
facilitate signaling through the BCR.
CD81 Is Required for Mediating BCR Signaling after
Cytoskeleton Disruption
We went on to ascertain the functional significance of CD81-
mediated immobilization of CD19 in BCR-mediated signaling
triggered by cytoskeleton disruption. Indeed, CD81-deficient B
cells were severely impaired in their ability to trigger calcium
signaling after treatment with LatA (Figure 5A). Moreover, this
was accompanied by a clear reduction in the phosphorylation
of downstream effectors such as ERK and Akt (Figures 5B and
5C). This reduced signaling does not result from the reported
reduction in CD19 expression in the absence of CD81 (Maecker
and Levy, 1997), as shown by the fact that B cells from double
heterozygous offspring (Cd19+/Cd81+/) expression matched
for CD19 were able to mount a robust response (Figure S4).
However, in line with previous investigations (Tsitsikov et al.,
1997) and similarly to CD19-deficient cells, the signaling result-
ing from cross-linking of BCR with soluble antigen was not
affected (Figures 5D–5F).
These observations suggest that the regulation of CD19
mobility and organization by CD81 is indeed functionally impor-
tant for BCR-mediated signaling after cytoskeleton disruption.
Thus, the tetraspanin network appears to hold CD19 signaling
scaffolds in place to interact with mobile BCR nanoclusters
released after cortical cytoskeleton disruption. Intriguingly,
because such a mechanism does not require all BCRs to be
engaged by antigen, this might provide a means of amplifying
signaling through the BCR during activation.r the indicated time. Cells were lysed and analyzed by SDS-PAGE followed by
-ERK), and total ERK1 and 2 (ERK).
e (A–C) after stimulation with 10 mg/ml anti-IgM F(ab)2.
table tyrosines are highlighted with amino acid numbers along with the known
(Y391F, Y421F, Y490F); and CD19-2Y (Y391F, Y403F, Y421F, Y443F, Y490F).
)2 or (right) 1 mMLatA in primary B cells expressing (top)WTCD19, (second row)
g2 were examined as in (H).
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Figure 4. The Tetraspanin CD81 Organizes and Immobilizes CD19
Nanoclusters
(A–F) Single-particle tracking of CD19 and IgD in wild-type (WT) or CD81-
deficient primary B cells settled on nonstimulatory coverslips.
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for Cytoskeleton Disruption
Thus far we have established the importance of CD81-mediated
immobilization of CD19 when BCR signaling is initiated through
disruption of the cytoskeleton. But how does this relate to the
predominant physiological situation where B cell activation is
triggered after BCR engagement by antigen on the surface of
a presenting cell?
To examine the possible changes in the organization of BCR
and CD19 nanoclusters during antigen-induced activation, we
visualized endogenous receptors at high resolution in cells
settled on an antigen-containing surface via dSTORM. Primary
B cells expressing BCR specific for hen egg lysozyme (HEL;
MD4) (Goodnow et al., 1988) were labeled with Cy5-conjugated
Fab fragments against IgM, IgD, or CD19 and settled on cover-
slips coated with HEL. Reconstructed dSTORM images were
examined with both the Hopkins index and the H function, as
previously described (Figures 6A, 6B, S5A, and S5B). We
observed no significant difference in the distribution of either
BCR isotype or CD19 upon activation as measured by the Hop-
kins index, though we did detect a slight alteration in the aggre-
gation of IgD (Figure 6B). Thus, similar to the signaling after
alteration of the actin cytoskeleton, it appears that the nanoclus-
ter organization of IgM or IgD does not dramatically change upon
antigen-induced activation. Importantly, this was not due to
insufficient amount of antigen as shown by the fact that strong
stimulation occurred under these conditions (Figures S5C
and S5D).
Although the initiation of BCR signaling was not accompanied
by a global alteration in receptor organization, we observed
minor differences. This might be due to the fact that only a small
proportion of BCR that we visualized participate in BCR
signaling. To investigate this and locate the sites of active
signaling, we took advantage of B cells expressing the proximal(A) Transmitted light (left) and single particles (right) of CD19 with the tracks
showing diffusion up to 4 s.
(B) Magnified region (2.8 3 2.0 mm) from dashed rectangle in (A) showing the
movement (lines trace positions with color encoding time from cyan to red) of
two particles (current position highlighted in dashed orange and blue circles).
See also Movie S1.
(C) The diffusion of CD19 or IgD was measured before or after treatment with
1 mM LatA.
(D and E) Analysis of the CD19 diffusion coefficient plotted in a logarithmic
histogram and fitting to two distinct populations exhibiting slower (D) (light
gray) and faster (dark gray) diffusion, and (E) comparison of the diffusion of
CD19 in (light blue) wild-type and (dark blue) CD81-deficient cells (left) on
a logarithmic histogram and (right) by the proportion of the faster CD19.
(F) The diffusion of (left) CD19 or (right) IgD was measured before or after
treatment with 1 mMLatA. The median is given as value and indicated by black
bars. For single-particle tracking of CD19, 1,000–2,000 tracks were analyzed
with a minimum of 30 cells from 3 experiments.
(G and H) Primary B cells from WT or CD81-deficient mice were stained with
Cy5-conjugated CD19 antibody and settled on nonstimulatory coverslips.
Cells were then fixed, imaged, and processed for dSTORM.
(G) dSTORM images (left) of representative cells with magnified region (1.5 3
1.5 mm) in dashed white square shown as 3D surface plot (right).
(H) Quantification of the distribution of CD19 by (left) Hopkins index and (right)
H function. Data are pooled from three experiments and minimum of nine cells
per experiment. Error bars (Hopkins index) and thin lines (H function) denote
mean ± SEM. ***p < 0.0001.
Scale bars represent 1 mm (A, G). See also Figure S3.
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Figure 5. BCR Signaling in Response to Cytoskeleton Disruption Requires CD81
(A–C) Wild-type (WT) and CD81- and CD19-deficient primary B cells were treated with 1 mM LatA.
(A) Ratiometric intracellular calcium flux in (left) WT, (middle) CD81-deficient, and (left) CD19-deficient B cells measured by flow cytometry.
(B and C) B cells were treated with vehicle control for 5 min (DMSO, -) or LatA for the indicated time. Cells were lysed and analyzed by SDS-PAGE followed by
immunoblotting with phospho-Akt (Ser473 and Thr308), phospho-ERK1 and 2 (p-ERK), and total ERK1 and 2 (ERK).
(B) Immunoblot.
(C) Quantification of p-ERK and p-Akt.
(D–F) Wild-type (WT) and CD81- and CD19-deficient primary B cells were examined as above after stimulation with 10 mg/ml anti-IgM F(ab)2.
Data are representative of a minimum of three experiments. See also Figure S4.
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Membrane Organization Regulates BCR Signalingkinase Syk fused with GFP in the A20 B cell line expressing
HEL-specific transgenic IgM. Unlike IgM, GFP-Syk did not
form clusters under nonstimulatory conditions (Figure S5E).
Upon stimulation with surface-bound antigen, we observed
GFP-Syk-enriched signaling microclusters and IgM that colo-
calized (Figure S5F) and an increase in the Hopkins index for
IgM (Figure S5G). This indicates that BCR becomes lessrandomly organized, though analysis of the H function showed
no change in the overall size or density of BCR nanoclusters.
The slight increase in the H function only at intermediate
distances suggested that existing BCR nanoclusters maintain
their integrity but may move in closer proximity to each other
in response to antigen. Thus, we investigated the relative distri-
bution of BCR within or outside of signaling microclusters andImmunity 38, 461–474, March 21, 2013 ª2013 Elsevier Inc. 469
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Figure 6. BCR Nanoclusters Are Brought together during BCR Signaling
(A and B) MD4 primary B cells were stained with Cy5-conjugated anti-IgD or anti-IgM Fab fragments and settled either on nonstimulatory (control) or antigen
(HEL)-coated coverslips. Cells were then fixed, imaged, and processed for dSTORM.
(A) 3D surface plots (1.5 3 1.5 mm) of dSTORM images of representative cells (see Figures S5A and S5B, white dashed squares).
(B) Quantification of the distribution of (top) IgD and (bottom) IgM by (left) Hopkins index and (right) H function. Data are pooled from three experiments and
minimum of nine cells per experiment. Error bars (Hopkins index) and thin lines (H function) denote mean ± SEM.
(C–F) A20-D1.3 cells expressing GFP-Syk were stained with Cy5-conjugated anti-IgM Fab fragment, settled on antigen (HEL)-coated coverslips, fixed, and
imaged by dSTORM.
(C) dSTORM image of IgM (left), TIRF image of GFP-Syk (middle), and merge of the two (right) are shown. Scale bar represents 2 mm.
(D) Left and middle: A magnified region (33 3 mm) (top) as indicated by dashed white square in (C) and two further magnified regions (1.23 0.6 mm) (a and b) as
indicated by dashed white rectangle in top panels shown as dSTORM image of IgM (left) alone or (middle) together with binary mask of GFP-Syk-rich regions.
Right: By a clustering algorithm (see Supplemental Experimental Procedures), single-molecule localizations were classified as being clustered inside (red dots) or
outside (blue dots) of the GFP-Syk mask (light green) or individual localizations (gray dots). The size of each cluster is represented by open circles (black for
clusters inside and light blue for clusters outside GFP-Syk mask).
(E) Quantification of enrichment of IgM and CD19 inside or outside GFP-Syk mask; error bars denote mean ± SEM.
(F) Quantification of themolecular density of IgM clusters inside or outside GFP-Syk-rich areas, as shown in (F, right) or on cells settled on nonstimulatory surface.
Data are pooled from two experiments and minimum of nine cells per experiment. ***p < 0.0001. See also Figure S5.
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Membrane Organization Regulates BCR Signalingobserved 50% enrichment in BCR within GFP-Syk microclus-
ters (Figures 6C–6E). Importantly, the molecular density of IgM
within clusters did not change according to their location inside
or outside GFP-Syk-rich regions, and indeed this remained
unchanged compared with resting B cells (Figures 6F and
S5H). Moreover, though CD19 nanoclusters do not change
upon stimulation (Figures S5H–S5J), there was a similar enrich-470 Immunity 38, 461–474, March 21, 2013 ª2013 Elsevier Inc.ment of this coreceptor in GFP-Syk microclusters (Figure 6E).
The concomitant concentration of BCR and CD19 in signaling
microclusters provides support for the notion that pre-existing
nanoclusters of these two receptors are brought together at
sites of active signaling. Thus, antigen-induced B cell activation
triggers the modest enrichment of BCR and CD19 at signaling
microclusters, though the receptors themselves appear to
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Figure 7. CD81 Regulates B Cell Activation
by Membrane-Bound Antigen
Wild-type (WT) and CD81-deficient cells were
settled on fluid lipid bilayers containing anti-kappa
light chain as antigen, visualized by ATTO 633-
conjugated streptavidin, and imaged by live
TIRFM for up to 5 min.
(A) Transmitted light image (left) and antigen
channel (middle left) showing the formation of
antigen microclusters at the maximum spread of
the cells. Cell spreading (middle right) was as-
sessed from the outline of the area occupied by
antigen microclusters (red line) and the number of
microclusters per cell (right) was counted (orange
line). See also Movie S2. Scale bars represent
1 mm.
(B andC) Quantification of the (B)maximum area of
spreading and (C) number of antigen micro-
clusters, as (left) a dot plot with each dot repre-
senting a single cell and (right) a histogram where
relative frequencies are fitted to a Gaussian
distribution. Data are representative of 3 experi-
ments and minimum of 70 cells. Red bar is mean ±
SEM. ***p < 0.0001.
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the resting B cell.
Finally, to establish whether the CD81-mediated organization
of CD19 was important during BCR signaling in response to
antigen, we examined the extent of B cell activation in CD81-
deficient B cells. We observed that these cells were significantly
reduced in their ability to spread and form antigen microclusters
in response to anti-BCR on amembrane surface (Figure 7; Movie
S2). This impairment is reminiscent of that observed previously
for CD19 (Depoil et al., 2008) and further strengthens the sugges-
tion that these two receptors are functionally linked during
antigen-induced B cell activation in vivo.
Taken together, antigen-induced B cell activation exhibits the
characteristic molecular requirements identified for BCR
signaling triggered by cytoskeleton disruption, namely the
collaboration between nanoclusters of BCR and coreceptor
CD19 that are organized by the cortical actin cytoskeleton and
the CD81-containing tetraspanin network. As such, we suggestImmunity 38, 461–47that the tetraspanin-mediated immobili-
zation of coreceptor CD19 provides
a means to propagate the signal from
mobile BCR nanoclusters, establishing
a potential mechanism underlying the
essential role of CD19 during B cell acti-
vation in vivo.
DISCUSSION
Here, we have demonstrated that endog-
enous IgM and IgD and the coreceptor
CD19 are differentially organized into pre-
formed nanoscale oligomeric assemblies
in the plasma membrane of resting
primary B cells. We have shown that the
BCR is necessary but not sufficient forsignaling triggered by disruption of the actin cytoskeleton,
because this also requires immobilization of CD19 through the
CD81-tetraspanin network. We suggest that differential
compartmentalization of receptors through the cytoskeleton
and the tetraspanin network plays an important role in controlling
BCR signaling. Such a mechanism is important not only during
antigen-induced activation of B cells, but also may have implica-
tions for the ligand-independent signaling necessary for B cell
development and survival.
Historically it has been assumed that ligand-mediated cross-
linking of monomeric BCR triggers signaling and consequent B
cell activation. In support of this view, FRET experiments have
suggested that the BCR exists as a monomer in resting J558L
B cells (Tolar et al., 2005). However, the observation that an
enormous range of molecularly diverse antigens is capable
of triggering BCR signaling and B cell activation calls into
question the simple cross-linking model (Yang and Reth,
2010a, 2010b). To better understand the molecular mechanism4, March 21, 2013 ª2013 Elsevier Inc. 471
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resolution microscopy to visualize the organization of endoge-
nous BCR with accuracy of 20 nm in primary B cells. We
observed that both IgD and IgM exist as preformed nanoclus-
ters in resting B cells. The concept of preclustered BCR is in
line with previous blue native polyacrylamide gel electropho-
resis studies (Schamel and Reth, 2000). With dSTORM, we
make no assumption as to the nature of the immunoreceptor
interactions within the clusters we could detect, and we refer
to them as nanoclusters rather than oligomers, which would
indicate direct protein-protein interactions. Instead, we have
provided quantitative insight into the size and molecular
composition of BCR nanoclusters, showing that typical clusters
of approximately 60–80 nm radius contain around 30–120 and
20–50 molecules of IgD and IgM, respectively. In view of the
relatively large number of molecules per BCR nanocluster, we
suggest that this organization resembles that of the ‘‘protein
islands’’ reported for the TCR in the resting T cell membrane
(Lillemeier et al., 2010). At this stage it remains unclear what
determines the differential clustering behavior between IgM
and IgD.
The nanoscale organization of both IgD and IgM did not
appear to be dramatically changed at early times after activation
by surface-bound antigen, as evidenced by the maintenance of
both the molecular density and proportion of BCR found in the
nanoclusters. This observation indicates that robust BCR
signaling can be initiated without a global reorganization of
receptors, such as that required during formation of the BCR
‘‘cap,’’ which typically covers one pole of the cell and is in the
scale of several micrometers (Unanue et al., 1972). We observed
an increase in receptor aggregation in GFP-Syk-rich areas after
stimulation with antigen, which is in line with the well-docu-
mented formation of submicrometer ranged antigen-enriched
signaling microclusters upon B cell encounter with membrane-
bound antigen (Depoil et al., 2008). Because this was not accom-
panied by a change in the molecular density within BCR nano-
clusters or decrease in the intermolecular distances, we expect
that BCR signaling is triggered by convergence of receptor
nanoclusters to form signaling microclusters. An alternative
mechanism suggested for the initiation of BCR signaling is based
on relaxation of pre-existing inactive BCR oligomers (Schamel
and Reth, 2000; Yang and Reth, 2010b). Although we do not
detect any dispersion of BCR in primary B cells at these early
stages, it remains possible that such relaxation is a later
phenomenon that is concomitant to the acceleration of BCR
we reported earlier (Treanor et al., 2011). Our current findings
also provide mechanistic insight into the requirement of CD19
for B cell activation in response to membrane-bound antigen
(Depoil et al., 2008). This reorganization would release pre-exist-
ing BCR nanoclusters, such that they can move into close prox-
imity with CD19, providing a mechanism to both facilitate and
amplify signaling through the BCR.
We recently suggested a model whereby tonic signaling is the
result of ligand-independent BCR signal that is generated by the
dynamic reorganization of the cortical cytoskeleton (Treanor
et al., 2010). Here, by taking advantage of genetics, we demon-
strate that BCR is absolutely required to trigger the robust
signaling observed upon cytoskeleton disruption. Because the
underlying actin cytoskeleton regulates BCR diffusion, it appears472 Immunity 38, 461–474, March 21, 2013 ª2013 Elsevier Inc.that the cytoskeleton and associated linkers operate respec-
tively as ‘‘fence’’ and ‘‘pickets’’ defining compartment bound-
aries, as suggested by Kusumi et al. (2005). This could structure
the plasma membrane in a way that the majority of pre-existing
BCR nanoclusters retain a quiescent state. However, we found
that the BCR alone is not sufficient to trigger the signaling in
response to cytoskeleton disruption but that this also requires
the coreceptor CD19. This demonstrates amore complex mech-
anism for BCR signaling than simple receptor cross-linking. We
suggest that cytoskeleton reorganization releases pre-existing
BCR nanoclusters to collaborate with CD19 to allow BCR
signaling. Furthermore, it is known that tonic signaling requires
the PI3K-FOXO pathway (Srinivasan et al., 2009) and that the
cytoplasmic domain of CD19 can mediate PI3K recruitment to
the BCR (Fearon and Carroll, 2000). Thus, tonic signaling could
be a result of receptor crosstalk facilitated by the dynamics of
the cortical actin cytoskeleton. As such, other receptor ligand
interactions, such as between BAFF and BAFF-R (Yan et al.,
2001), could as well trigger local cytoskeleton reorganization,
leading to CD19-dependent BCR signaling.
In addition to the actin cytoskeleton, we demonstrated a key
role for CD81-tetraspanin in organizing CD19 for optimal interac-
tions with BCR. The tetraspanin proteins are known to play a role
in compartmentalization of the plasma membrane. Interestingly,
CD81-deficient mice consistently exhibit abnormal antibody
response, but the underlying impact of CD81 on BCR signaling
remains unclear (Maecker and Levy, 1997; Miyazaki et al.,
1997; Tsitsikov et al., 1997). In line with previous reports, we
found that although CD81-deficient B cells are not impaired in
BCR signaling after heavy receptor cross-linking, they exhibit
diminished BCR signaling after stimulation with antigen on
a surface (Miyazaki et al., 1997). Here, we have not only revealed
a role for CD81 in restraining the diffusion of CD19 in the B cell
membrane, but also show that in the absence of CD81 B cells
were unable to trigger calcium signaling in response to cytoskel-
eton disruption. We suggest that this defect is caused by dysre-
gulated function of CD19, because both its diffusion and organi-
zation are altered in CD81-deficient B cells. Interestingly it has
been reported that CD81 can be palmitoylated (Cherukuri
et al., 2004). Such lipid modification could be responsible for
the localization of CD81 and associated CD19. As such, it
appears that the tetraspanin network, alongside the actin cyto-
skeleton, plays an important role in organizing compartments
within the B cell membrane to regulate signaling through
the BCR.
In addition to visualizing themolecular landscape of the recep-
tors, we have carried out a genetic dissection by using various
CD19 mutant constructs to provide insight into the molecular
mechanism underlying the requirement for CD19 during B cell
activation. We established that the CD19-mediated recruitment
of Vav, PLCg2, and PI3K were pivotal in transmitting the signal
upon disruption of the cytoskeleton. This suggests that CD19
functions as a scaffold for intracellular effectormolecules to facil-
itate signaling through BCR nanoclusters. Interestingly, the func-
tion of CD19 bears resemblance to LAT, the key adaptor mole-
cule in T cells, that recruits multiple intracellular effectors
promoting signaling through the TCR (Samelson, 2002). More-
over, it has been shown that the TCR and LAT occupy distinct
membrane domains in resting T cells, and after antigenic
Immunity
Membrane Organization Regulates BCR Signalingstimulation the areas of overlap would serve as hotspots for
signal amplification (Lillemeier et al., 2010; Sherman et al.,
2011). Indeed, in line with an analogous role for CD19, we de-
tected enrichment of both BCR and CD19 in the signaling micro-
clusters defined by GFP-Syk.
Overall, on the basis of our findings, we postulate the following
model underlying signaling through the BCR. In resting B cells,
pre-existing nanoclusters of BCR and CD19 exist in distinct
compartments in the plasma membrane defined by the actin
cytoskeleton. Upon engagement with antigen, the BCR triggers
signaling resulting in the local reorganization of the cytoskeleton,
releasing BCR nanoclusters to interact with CD19 that is sup-
ported by the CD81-tetraspanin network. As such, the coales-
cence of these nanoclusters facilitates the recruitment of down-
stream effector molecules and propagation of signaling utilizing
also BCR that is not directly engaged with antigen, ensuring
robust and rapid B cell activation in response to antigen. More-
over, in the absence of antigen, we suggest that dynamism of
the actin cytoskeleton might trigger BCR signaling for B cell
survival by a similar mechanism. Indeed, mutations in both
CD19 (Conley et al., 2009) and CD81 (van Zelm et al., 2010)
have been associated with antibody deficiency syndromes in
humans. This type of mechanism involving the compartmentali-
zation of receptors in the plasma membrane might provide
a widespread means of greatly amplifying signaling through
a number of important cell surface receptors.EXPERIMENTAL PROCEDURES
Cell Stimulation and Immunoblotting
Intracellular calcium flux was measured by flow cytometry with a ratiometric
indicator INDO-1, as described (Treanor et al., 2010), stimulating primary B
cells with LatA (Calbiochem), CytoD (Calbiochem), DMSO (Sigma, vehicle
control), or anti-IgM F(ab)2 (Jackson) in chamber buffer (0.5% FCS, 2 mM
Mg2+, 0.5 mM Ca2+, 1 g/l D-glucose in PBS). Optionally, the INDO-1-labeled
cells were stained with ATTO 633-labeled anti-mouse IgM Fab fragment on
ice prior to analysis. For immunoblotting with anti-phospho-p44 and 42
MAPK (ERK1 and 2) T202/Y204, anti-phospho-Akt S473, anti-phospho-Akt
T308, anti-p44 and 42 MAPK (Cell Signaling), or anti-b-actin (A1978, Sigma),
cells were equilibrated in RPMI at 37C for 10 min prior to stimulation. All
experiments involving usage of animals were approved by the Cancer
Research UK Animal Ethics Committee and the UK Home Office.Sample Preparation for Microscopy
For single-particle tracking, primary B cells were incubated with limiting dilu-
tions of Alexa Fluor 555- or ATTO 633-conjugated anti-CD19 Fab (1D3), anti-
IgD Fab (11-26c), or anti-IgM Fab (Jackson ImmunoResearch) for 15 min on
ice, washed with PBS, resuspended in chamber buffer, and settled on anti-
MHCII-coated coverslips at 37C for 10 min prior to imaging with TIRFM for
5 min. For disruption of F-actin, 1 mM LatA prewarmed in chamber buffer
was injected into the chambers 15 min after settling of the cells and imaged
5–10 min after adding the drug. For dSTORM, cells were labeled as above
with Cy5-conjugated Fab fragments (anti-IgM [Jackson ImmunoResearch],
anti-IgD 11-26c, anti-IgD LOMD6, anti-CD19 6D5) or antibodies (anti-CD19
6D5) and allowed to adhere for 4 min. For receptor cross-linking, anti-IgM
F(ab)2 or secondary anti-rat antibody against anti-IgD Fab were used. LatA
or DMSO was added for another 4 min. The samples were fixed (4% parafor-
maldehyde, 0.2% glutaraldehyde in PBS) for 40 min and imaged in dSTORM
switching buffer (PBS [pH 7.4] [Sigma], 0.1 M b-mercaptoethylamine [Sigma])
with colloidal gold particles (40 nm or 100 nm diameter, British Biocell) as fidu-
cials. MD4 transgenic B cells were used for their relatively uniform expression
BCR. dSTORM data were analyzed as explained in Supplemental Experi-
mental Procedures.Microscopy
TIRFM images were acquired with an EMCCD camera (iXon3 897, Andor)
coupled to a TIRFM system (Cell R, Olympus) with three laser lines (488 nm,
561 nm, and 640 nm) and motorized filter wheel (Olympus). Single-particle
tracking was performed as previously described (Treanor et al., 2010). For
dSTORM, a 1503 NA 1.45 objective (Olympus) was used with the lasers
adjusted to intensities of <50 W/cm2 and approximately 250 W/cm2 for the
488 nm and 640 nm laser lines, respectively. Generally, 2,000–5,000 frames
were acquired at 640 nm with exposure time of 200–300 ms and simultaneous
activation at 488 nm. For lipid bilayers, 1003 NA 1.45 objective with 1.63
magnification changer (opto var, Olympus) was used.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2012.11.019.
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